Please assess the completion status of the following clinical trial:

Trial Title: Carbon Ion Radiotherapy for Hepatocellular Carcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* histologically confirmed HCC or diagnosis of HCC according to AASLD-guidelines~* macroscopic tumor~* liver-confined disease without extrahepatic disease as diagnosed by CT, MRT, ultrasound and bone scan~* minimal distance of tumor edge to the intestines of 1cm~* age ≥ 18 years of age~* Karnofsky Performance Score ³60~* For women with childbearing potential, (and men) adequate contraception.~* Ability of subject to understand character and individual consequences of the clinical trial~* Written informed consent (must be available before enrolment in the trial)~Exclusion Criteria:~* refusal of the patients to take part in the study~* previous radiotherapy of the hepatobiliary system~* margin of \< 1cm between tumor edge and intestines~* Patients who have not yet recovered from acute toxicities of prior therapies~* Known carcinoma \< 2 years ago (excluding Carcinoma in situ of the cervix, basal cell carcinoma, squamous cell carcinoma of the skin) requiring immediate treatment interfering with study therapy~* Pregnant or lactating women~* Participation in another clinical study or observation period of competing trials, respectively

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Carbon Ion Radiotherapy (Type: EXPERIMENTAL): Increasing Dose of Carbon Ion Radiotherapy 4 x 10 Gy E to 4 x 14 Gy E

Based on this trial design, predict the completion outcome and termination type (if applicable).